Immune Escape in Breast Cancer During <i>In Situ</i> to Invasive Carcinoma TransitionCarlos R. Gil Del Alcazar, Kornélia Polyák, Judy E. Garber et al.|Cancer Discovery|2017Cited by 242
Spatial Proximity to Fibroblasts Impacts Molecular Features and Therapeutic Sensitivity of Breast Cancer Cells Influencing Clinical OutcomesAndriy Marusyk, Kornélia Polyák, Doris P. Tabassum et al.|Cancer Research|2016Cited by 140
Intratumor heterogeneity defines treatment‐resistant <scp>HER</scp> 2+ breast tumorsInga Hansine Rye, Hege G. Russnes, Anne Trinh et al.|Molecular Oncology|2018Cited by 102
JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell StatesLaura E. Stevens, Kornélia Polyák, Guillermo Peluffo et al.|Cancer Research|2022Cited by 101
Acquired resistance to combined BET and CDK4/6 inhibition in triple-negative breast cancerJennifer Y. Ge, Kornélia Polyák, Shaokun Shu et al.|Nature Communications|2020Cited by 97